Dewpoint Therapeutics Stock
Dewpoint Therapeutics focuses on drug discovery across oncology, neurodegenerative, cardiopulmonary, and metabolic diseases using an AI-powered platform. It specializes in visualizing and targeting biomolecular condensates to prevent harmful protein aggregation, collaborating with top academic and pharmaceutical entities to develop innovative therapies.
Founded: 2018
For more Dewpoint Therapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Ameet Nathwani Chief Executive Officer & Board Member |
| Lori Escobedo Chief People Officer |
| Isaac Klein Chief Scientific Officer |
| Dean Mula Vice President & Corporate Controller |
| Anthony Hyman Co-Founder & Board Member |
| Richard Young Co-Founder & Board Member |
